Expression of FGF23/KLOTHO system in human vascular tissue.
about
Klotho in cardiovascular disease: Current and future perspectivesSignificant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular diseaseCardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Diseaseα-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cellsFibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.FGF23 protein expression in coronary arteries is associated with impaired kidney function.αKlotho and vascular calcification: an evolving paradigm.FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.Implications of Klotho in vascular health and disease.Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification.FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease.Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus.Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells.αKlotho and Chronic Kidney Disease.Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.Reduced Klotho is associated with the presence and severity of coronary artery disease.
P2860
Q26775409-9C8BFB13-0783-4E6B-9B21-A2EB8A8460FAQ26782946-6811C497-7EC1-4C8F-AEDF-1BE80856B00CQ27024043-B56F95A1-DF63-41C9-B64B-63DC834B08FFQ33626706-72B8BFB7-ACD3-43D9-B5F9-C910061F7AFBQ33650866-E99E259F-B631-41E1-97C8-A8FF643900E3Q33985430-6D9D5790-1778-4CB4-80A8-9EAC53F25468Q34078872-32C16BC0-1A0D-431A-BC55-CEA985ED1148Q34130840-E277DBFA-CB67-4E98-9DBA-846507F4E51CQ34780123-FC66678C-EA9A-432B-8DE9-80164E4D36EAQ35667633-FC719B6B-C16D-4430-A872-C061B936815CQ35967107-979554D5-5975-4847-B50B-6E9FA7EB22AFQ36287699-805E489E-8B46-4C49-BBA2-8A468CD002ECQ36443208-659C2166-C984-43F4-B2B9-1C2203D6D0ADQ36476878-D78D633A-84DB-444D-93EE-993BEC0B2920Q36520483-85E508F5-A822-43BC-A57C-CE571160EFACQ37333243-C0D51082-F31F-484F-B7B2-95D20FB320D0Q39009566-F5D66FE6-BAC9-4BAA-AF30-6A95F6E5C150Q39569165-66CED0C4-E886-4779-96DD-C335E3AA034FQ39812781-6651D4D6-4F49-41E0-BBC8-35C0AB9587F1Q41497001-4FB5CB21-D176-4570-8ACC-F24C8A04008AQ52718518-781AFB5F-627E-408F-BE2C-F84BA46A9B77Q52934731-4521B300-6856-4C0B-852D-6EDEC63601B4Q54237788-259D2AA7-53A6-41C8-B924-6CF7413783D2
P2860
Expression of FGF23/KLOTHO system in human vascular tissue.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Expression of FGF23/KLOTHO system in human vascular tissue.
@en
Expression of FGF23/KLOTHO system in human vascular tissue.
@nl
type
label
Expression of FGF23/KLOTHO system in human vascular tissue.
@en
Expression of FGF23/KLOTHO system in human vascular tissue.
@nl
prefLabel
Expression of FGF23/KLOTHO system in human vascular tissue.
@en
Expression of FGF23/KLOTHO system in human vascular tissue.
@nl
P2093
P50
P1476
Expression of FGF23/KLOTHO system in human vascular tissue
@en
P2093
Beatriz Meneses-Pérez
Horacio Pérez
Mercedes Muros-de-Fuentes
Rafael Martínez-Sanz
Violeta Cazaña-Pérez
P304
P356
10.1016/J.IJCARD.2011.08.850
P407
P577
2011-09-25T00:00:00Z